State of Alaska Department of Revenue’s NovoCure NVCR Stock Holding History

State of Alaska Department of Revenue’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-22,850	Closed	-$357K	–	1603
2024 Q3	$357K	Hold	22,850	–	–	﹤0.01%	1510
2024 Q2	$391K	Hold	22,850	–	–	﹤0.01%	1449
2024 Q1	$357K	Hold	22,850	–	–	﹤0.01%	1487
2023 Q4	$341K	Hold	22,850	–	–	﹤0.01%	1511
2023 Q3	$369K	Hold	22,850	–	–	﹤0.01%	1454
2023 Q2	$948K	Hold	22,850	–	–	0.01%	1011
2023 Q1	$1.37M	Hold	22,850	–	–	0.02%	818
2022 Q4	$1.68M	Buy	22,850 +9,227	+68%	+$694K	0.02%	711
2022 Q3	$1.03M	Buy	13,623 +11,176	+457%	+$872K	0.01%	896
2022 Q2	$170K	Buy	+2,447	New	+$184K	﹤0.01%	1601
2021 Q4	–	Sell	-1,623	Closed	-$188K	–	1649
2021 Q3	$188K	Buy	1,623 +368	+29%	+$55.6K	﹤0.01%	1614
2021 Q2	$278K	Buy	1,255 +722	+135%	+$140K	﹤0.01%	1584
2021 Q1	$70K	Buy	+533	New	+$84.3K	﹤0.01%	1644

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State of Alaska Department of Revenue's NVCR Position: Q4 2024 in Review

State of Alaska Department of Revenue sold out of NovoCure (NVCR) in Q4 2024, closing a stake of 22,850 shares — an estimated $357K sold.

State of Alaska Department of Revenue first reported a position in NVCR in Q1 2021 and held it in 13 quarters. The position peaked at $1.68M in Q4 2022. 239 funds tracked by Wall St. Rank hold NVCR as of Q4 2024.

State of Alaska Department of Revenue reported no remaining NovoCure position as of Q4 2024 after selling out during the quarter.
State of Alaska Department of Revenue sold 22,850 NovoCure shares in Q4 2024, an estimated $357K.
State of Alaska Department of Revenue first reported a position in NovoCure in Q1 2021 and held it in 13 quarters.
State of Alaska Department of Revenue's NovoCure position peaked at $1.68M in Q4 2022.
239 funds tracked by Wall St. Rank held NovoCure as of Q4 2024.

Based on State of Alaska Department of Revenue's 13F filing for Q4 2024, filed 27 Jan 2025.